Drug Trial Radar · NCT05697614
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
Last checked: Nov 19, 2026Latest source record: Jan 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 1, 2023
Primary completion
May 30, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- Dr Cipto Mangunkusumo General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 1 year, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this interventional study is to learn about the efficacy and safety of first line anti epileptic drugs (AEDs) as substitution therapy for children who are resistant to second-line AEDs. The main question to answer it aims are : how much the difference proportion of responders (responders are children who achieve the decrease of seizure frequencies by 50%) how much time it is needed to achieve the decrease of seizure frequencies by 50% The patients who are eligible for the study and have given their consent, will be enrolled, divided into 2 groups, the control and intervention. The participant should follow the 14 weeks of intervention that consists of 6 phases : baseline, initial dose, titration dose, maintenance dose, tapering-off dose, and new combination maintenance dose.
Conditions
- Drug Resistant Epilepsy
Interventions
Valproic acidDrug
valproic acid is used for general epilepsy type, used in experimental group
CarbamazepinDrug
carbamazepine is used for focal type epilepsy, used in experimental group
PhenytoinDrug
phenytoin is used for both general or focal epilepsy in case valproic acid or carbamazepine is contraindicated, used in experimental group
LamotrigineDrug
lamotrigine is used for general epilepsy type, used in control group
ClobazamDrug
clobazam is used for both general or focal epilepsy in case if lamotrigine or oxcarbazepine is not possible to be administered and is used particularly in myoclonic jerk , used in control group
OxcarbazepineDrug
oxcarbazepine is used for focal type epilepsy, used in control group
Primary outcomes
What the sponsor says the trial is designed to measure.
- the different proportion of responders between groups who get first-line anti-epileptic drugs (intervention) and second-line anti-epileptic drugs (control)Time frame: trough the study completion, about 14 weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Harapan Kita Hospital
Jakarta, Indonesia · Recruiting
Fatmawati Hospital
Jakarta, Indonesia · Recruiting
Cipto Mangunkusumo Hospital
Jakarta Pusat, Jakarta Special Capital Region, Indonesia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.